Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-08-22 2019-09-19 92151
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-08-22 2019-11-21 92154
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
ACT ESCITALOPRAM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-02-21 99971
ACT ESCITALOPRAM ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-02-21 99974
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-09-24 2020-10-30 124992
TEVA-ZOLMITRIPTAN OD 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-10-22 2020-11-26 126933
TEVA-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-02-18 2021-04-15 134340
ACT ESCITALOPRAM ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-04-29 2021-07-09 138282
TEVA-ZOLMITRIPTAN OD 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-09-30 2021-10-07 146472
ACT ESCITALOPRAM ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-03-24 2022-05-05 157265
ACT ESCITALOPRAM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-03-31 2022-06-17 157637
TEVA-ZOLMITRIPTAN OD 2.5MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2022-05-19 2022-12-01 161012
TEVA-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-09-22 2023-04-28 169983
ACT ESCITALOPRAM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-09-22 2023-06-09 169990
ACT ESCITALOPRAM ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-09-22 2023-06-09 169995
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-02-09 2023-04-28 184213
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-10-05 2023-11-09 206428

Showing 2661 to 2680 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623

Showing 1 to 20 of 250